Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
about
Carriers for the tunable release of therapeutics: etymological classification and examples.The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulationIntravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: PharmacodynamicsA sustained intravitreal drug delivery system with remote real time monitoring capability.Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.Self-Setting Calcium Phosphate Cements with Tunable Antibiotic Release Rates for Advanced Antimicrobial ApplicationsNanostructured porous silicon-mediated drug delivery.Silicon nanostructures for cancer diagnosis and therapy.Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives.From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.Lipid Bilayer Membrane in a Silicon Based Micron Sized Cavity Accessed by Atomic Force Microscopy and Electrochemical Impedance Spectroscopy.Fabrication of Solid State Nanopore in Thin Silicon Membrane Using Low Cost Multistep Chemical Etching.New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies.Leveraging Physiology for Precision Drug Delivery
P2860
Q30367806-64825457-06EE-437D-85A3-89C9F82B9F2AQ34270352-24E35B91-D400-474C-9F3D-F76599F6612CQ34657063-A2285943-EA4D-4CAF-9718-0DA178C76CFAQ35087664-00F5DA85-5FF5-432F-8AA5-0BA0AEDB3E43Q35164657-80EE9CEC-0593-42B6-A6B9-9C8FE158E7C4Q35560465-869C59A4-788D-473F-A19D-1A91F4E1AF11Q36029456-B64654AC-7DDD-41F4-AEF6-CB1E8DF3DD51Q36592576-28B8F9D4-3FDB-4D2D-BFB1-A37E5581FA6EQ37211690-2FAA5D6D-B166-4FF3-AE3F-3189DA21842FQ38221242-B6F7967F-BF0A-4931-9EEA-9ED3027663D1Q38541957-DE602B88-6EDB-4AD6-85D1-68800F1A6E19Q38732021-9FD2556D-3C59-4FCC-B0BE-4F5CC7D2F37EQ39423232-845170FE-6B1F-4002-BB1E-25AF41C6181BQ41663721-E59203A9-AD93-413A-B3CF-E75FAAD31056Q42222112-ED07CEF6-5E36-4A79-885C-12F41BC76BA1Q49815957-92D66DEF-8987-46F9-9732-12D4741DF77DQ57428850-C4A03B64-A4F3-49F3-B480-4EA59218864C
P2860
Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tunable sustained intravitreal ...... using oxidized porous silicon.
@en
Tunable sustained intravitreal ...... using oxidized porous silicon.
@nl
type
label
Tunable sustained intravitreal ...... using oxidized porous silicon.
@en
Tunable sustained intravitreal ...... using oxidized porous silicon.
@nl
prefLabel
Tunable sustained intravitreal ...... using oxidized porous silicon.
@en
Tunable sustained intravitreal ...... using oxidized porous silicon.
@nl
P2093
P2860
P1476
Tunable sustained intravitreal ...... using oxidized porous silicon
@en
P2093
Huiyuan Hou
Lingyun Cheng
Michael J Sailor
William R Freeman
P2860
P356
10.1016/J.JCONREL.2014.01.003
P407
P577
2014-01-11T00:00:00Z